[HTML][HTML] Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD‑induced obese mice

M Li, A Sharma, C Yin, X Tan… - Molecular medicine …, 2017 - spandidos-publications.com
The present study aimed to investigate the effect of metformin on the induction of autophagy
in the liver and adipose tissues of a mouse model of obesity. C57BL/6J mice were fed a high …

Morin attenuates hepatic insulin resistance in high-fat-diet-induced obese mice

J Naowaboot, S Wannasiri, P Pannangpetch - Journal of physiology and …, 2016 - Springer
Morin is a natural bioflavonoid that exhibits antioxidant and anti-inflammatory properties.
The present study was designed to evaluate the effect of morin on insulin resistance …

Gemfibrozil reduces lipid accumulation in SMMC‑7721 cells via the involvement of PPARα and SREBP1

X Zhang, S Wang, L Hu, J Wang… - Experimental and …, 2019 - spandidos-publications.com
Gemfibrozil (GEM) is a member of the fibrate class of lipid‑lowering pharmaceuticals and
has been widely used in the therapy of different forms of hyperlipidemia and …

Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats

Y Sui, X Kong, R Fan, Y Ye, H Mai, S Zhuo… - Diabetology & Metabolic …, 2019 - Springer
Background Treatment with metformin, the biguanide of hepatic insulin sensitizer, in patients
with non-alcoholic fatty liver disease (NAFLD) has been reported with contradictory findings …

Metformin prevents fatty liver and improves balance of white/brown adipose in an obesity mouse model by inducing FGF21

EK Kim, SH Lee, JY Jhun, JK Byun… - Mediators of …, 2016 - Wiley Online Library
Obesity and its associated metabolic disorders are related to the onset of fatty liver and the
balance of white adipose tissue (WAT) and brown adipose tissue (BAT). We hypothesized …

Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding …

L Shi, L Shi, G Song, H Zhang, Z Hu, C Wang… - European journal of …, 2013 - Elsevier
The aim of this study was to examine the therapeutic effect of oxymatrine, a monomer
isolated from the medicinal plant Sophora flavescens Ait, on the hepatic lipid metabolism in …

Effects of metformin combined with lactoferrin on lipid accumulation and metabolism in mice fed with high-fat diet

QQ Min, LQ Qin, ZZ Sun, WT Zuo, L Zhao, JY Xu - Nutrients, 2018 - mdpi.com
Metformin (Met) and lactoferrin (Lf) both exhibit beneficial effects on body weight
management and lipid accumulation. However, the synergistical action of Met and Lf …

Metformin in combination with malvidin prevents progression of non-alcoholic fatty liver disease via improving lipid and glucose metabolisms, and inhibiting …

W Zou, C Zhang, X Gu, X Li, H Zhu - Drug design, development …, 2021 - Taylor & Francis
Background Non-alcoholic fatty liver disease (NAFLD) is one of the primary causes of
chronic liver disease and is closely linked to insulin resistance, type 2 diabetes mellitus …

[HTML][HTML] Fisetin protects against hepatic steatosis through regulation of the Sirt1/AMPK and fatty acid β-oxidation signaling pathway in high-fat diet-induced obese mice

CJ Liou, CH Wei, YL Chen, CY Cheng… - Cellular physiology and …, 2018 - karger.com
Background/Aims: Fisetin is a naturally abundant flavonoid isolated from various fruits and
vegetables that was recently identified to have potential biological functions in improving …

Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats

MA Linden, KT Lopez, JA Fletcher… - Applied Physiology …, 2015 - cdnsciencepub.com
Weight loss is recommended for patients with nonalcoholic fatty liver disease (NAFLD),
while metformin may lower liver enzymes in type 2 diabetics. Yet, the efficacy of the …